查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842073

美國家庭輸液治療市場：市場規模、佔有率、趨勢分析（按類型和應用）、細分市場預測（2025-2033 年）

U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type, By Application, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國家庭輸液治療市場概覽

據估計，2024 年美國家庭輸液治療市值為 204.2 億美元，預計到 2033 年將達到 399.6 億美元，2025 年至 2033 年的複合年成長率為 7.78%。

老年人口不斷成長，且老年人容易患上嚴重的健康問題，這是推動市場成長的主要因素。

此外，癌症、糖尿病、慢性疼痛和胃腸道疾病等疾病的日益普遍預計將進一步推動美國市場的成長。居家輸液療法為患者帶來許多好處，包括成本效益高、改善健康狀況、更便捷以及安全標準更高。

老齡化是感染疾病及其併發症的主要風險因素之一。因此，美國人口的快速老化預計將推動市場成長。例如，根據美國國家人口問題研究所的數據，預計65歲及以上人口將從2022年的5,800萬增加到2050年的8,200萬人。越來越多的患者選擇居家治療也是推動市場成長的因素之一。居家醫療保健能夠幫助患者進行日常活動，並提供更方便的專業醫療服務。與住院治療相比，居家輸液治療無需住院，因此更具成本效益，減輕了患者的負擔。此外，居家輸液治療還能降低病患在家中發生醫院感染的風險，進而確保更高的安全性。這些因素共同推動了居家治療的需求，並促進了市場成長。

美國癌症、糖尿病和其他慢性疾病的高發生率進一步推動了市場成長。根據美國癌症協會預測，2022年美國將新增近190萬例癌症病例，並有609,360例癌症相關死亡病例。糖尿病在美國的盛行率也相當高，這主要歸因於不良的生活方式和壓力巨大的工作環境。此外，心血管疾病和慢性呼吸系統疾病的盛行率在美國也持續快速上升。預計在預測期內，老年人口的成長和外科手術量的增加等因素也將推動美國對靜脈輸液幫浦的需求。

此外，各國政府預計將推出更嚴格的法規並採納新的標準，以提供更安全、更有效率的醫療服務。這項進展將透過提升國家醫療服務標準（包括輸液治療實踐標準、輸液護理政策和流程）以及改善個別醫護人員的政策來實現。此外，新產品的上市和FDA的核准也顯著促進了市場成長。例如，2024年4月，百特公司（Baxter）的Novum IQ大容量輸液幫浦和Dose IQ安全軟體獲得了美國FDA的批准。這項進步將增強互聯智慧輸液治療，進而提高病患安全性和醫療效率。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國家庭輸液治療市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國家庭輸液治療市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章：美國家庭輸液治療市場：按類型分類的估算與趨勢分析

  • 細分儀表板
  • 美國家庭輸液治療市場：按類型分類的差異分析
  • 美國家庭輸液治療市場規模及趨勢分析（按類型分類）（2021-2033 年）
  • 產品
    • 點滴幫浦
    • 靜脈輸液裝置
    • 靜脈套管
    • 無針頭連接器
  • 服務

第5章美國家庭輸液治療市場：按應用分類的估算與趨勢分析

  • 細分儀表板
  • 美國家庭輸液治療市場：按應用分類的差異分析
  • 美國家庭輸液治療市場規模及應用趨勢分析（2021-2033）
  • 抗感染疾病
  • 內分泌學
    • 糖尿病
    • 其他
  • 水療法
    • 運動員
    • 其他
  • 化療
  • 經腸營養
  • 腸外營養
  • 特種製藥
  • 其他

第6章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/上市公司
    • B. Braun Melsungen
    • Baxter International
    • Caesarea Medical Electronics Ltd.
    • CareFusion
    • Fresenius Kabi
    • ICU Medical
    • JMS CO., LTD.
    • Smiths Medical, Inc.
    • Terumo Corporation
    • Coram LLC
    • Option Care Enterprises, Inc.
    • BioScrip, Inc.
    • BriovaRx Infusion Services
    • Paragon Healthcare
Product Code: GVR-3-68038-956-2

U.S. Home Infusion Therapy Market Summary

The U.S. home infusion therapy market size was estimated at USD 20.42 billion in 2024 and is expected to reach USD 39.96 billion by 2033, growing at a CAGR of 7.78% from 2025 to 2033. The increasing elderly population susceptible to severe health conditions is a significant factor driving market growth.

In addition, the rising prevalence of disorders such as cancer, diabetes, chronic pain, and gastrointestinal diseases is anticipated to further stimulate growth in the U.S. market. Home infusion therapy provides various advantages for patients, including cost-effectiveness, improved health outcomes, enhanced convenience, and elevated safety standards.

Aging is one of the leading risk factors for developing infections and associated complications. Thus, the rapidly aging U.S. population is anticipated to drive market growth. For instance, according to the Population Reference Bureau, the number of people aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Increasing patients' preference for home therapy is also driving the market growth. Home healthcare supports the daily life activities of patients and provides better access to skilled medical care. As compared to hospital treatment, home infusion therapy is cost-effective since it eliminates hospital stays and ultimately saves the patient's money. Home infusion therapy also allows the patient to maintain higher safety due to less risk of hospital-acquired infections at home. This augments the demand for home treatment, thereby driving the market growth.

This country's high prevalence of cancer, diabetes, and other chronic diseases propels market growth further. According to the American Cancer Society, nearly 1.9 million new cancer cases were expected to be diagnosed with 609,360 cancer deaths in 2022. The prevalence of diabetes in the U.S is also quite significant, which can be attributed to negative lifestyle choices and a stressful work environment. Moreover, there has been a constant surge in the prevalence of cardiovascular and chronic respiratory diseases in the country. In addition, factors such as a growing geriatric population and increasing volume of surgical procedures are expected to propel the country's demand for intravenous infusion pumps in the forecast period.

Moreover, the government is expected to introduce stricter regulations and adopt new standards for safer & efficient practices. This progress is being achieved by improving national standards of care via the Infusion Therapy Standards of Practice and the Policies and Procedures for Infusion Nursing, along with upgrading policies of individual care providers. Moreover, new product launches and FDA approvals significantly contribute to market growth. For instance, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump and Dose IQ safety software. This advancement enhances connected and intelligent infusion therapy, improving patient safety and care efficiency.

U.S. Home Infusion Therapy Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. home infusion therapy market report based on Type, and application.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Product
    • Infusion PumpsIntravenous Sets
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
    • Intravenous Sets
    • IV Cannulas
    • Needleless Connectors
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Anti-infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Home Infusion Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing incidence of hospital-acquired infections
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of complicated reimbursement framework and reimbursement cuts
  • 3.3. U.S. Home Infusion Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. U.S. Home Infusion Therapy Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Home Infusion Therapy Market Type Movement Analysis
  • 4.3. U.S. Home Infusion Therapy Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Product
    • 4.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.2. Infusion pumps
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.2. Elastomeric
        • 4.4.2.2.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.3. Electromechanical
        • 4.4.2.3.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.4. Gravity
        • 4.4.2.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.5. Others
        • 4.4.2.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.3. Intravenous Sets
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.4. IV Cannulas
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.5. Needleless Connectors
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 5. U.S. Home Infusion Therapy Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Home Infusion Therapy Market Application Movement Analysis
  • 5.3. U.S. Home Infusion Therapy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Anti-Infective
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Diabetes
      • 5.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Hydration Therapy
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. Athletes
      • 5.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. Others
      • 5.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Chemotherapy
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Enteral Nutrition
    • 5.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Parenteral Nutrition
    • 5.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.10. Specialty Pharmaceuticals
    • 5.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. B. Braun Melsungen
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Baxter International
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Caesarea Medical Electronics Ltd.
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. CareFusion
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Fresenius Kabi
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. ICU Medical
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. JMS CO., LTD.
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Smiths Medical, Inc.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Terumo Corporation
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Coram LLC
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. Option Care Enterprises, Inc.
      • 6.4.11.1. Company overview
      • 6.4.11.2. Financial performance
      • 6.4.11.3. Product benchmarking
      • 6.4.11.4. Strategic initiatives
    • 6.4.12. BioScrip, Inc.
      • 6.4.12.1. Company overview
      • 6.4.12.2. Financial performance
      • 6.4.12.3. Product benchmarking
      • 6.4.12.4. Strategic initiatives
    • 6.4.13. BriovaRx Infusion Services
      • 6.4.13.1. Company overview
      • 6.4.13.2. Financial performance
      • 6.4.13.3. Product benchmarking
      • 6.4.13.4. Strategic initiatives
    • 6.4.14. Paragon Healthcare
      • 6.4.14.1. Company overview
      • 6.4.14.2. Financial performance
      • 6.4.14.3. Product benchmarking
      • 6.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. home infusion therapy market, by product, 2021 - 2033 (USD Million)
  • Table 3 U.S. home infusion therapy market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. home infusion therapy market: Market outlook
  • Fig. 5 U.S. home infusion therapy market: Segment outlook
  • Fig. 6 U.S. home infusion therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. home infusion therapy market driver impact
  • Fig. 9 U.S. home infusion therapy market restraint impact
  • Fig.10 U.S. home infusion therapy market: Type outlook and key takeaways
  • Fig.11 U.S. home infusion therapy market: Type movement analysis
  • Fig. 12 Infusion pumps market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Elastomeric market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Electromechanical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Gravity market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Intravenous sets market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 IV cannulas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Needleless connectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. home infusion therapy market: Application outlook and key takeaways
  • Fig. 21 U.S. home infusion therapy market: Application movement analysis
  • Fig. 22 Anti-infective market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 23 Endocrinology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Hydration therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Athletes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Chemotherapy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Enteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Parenteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Specialty pharmaceuticals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2021 - 2033 (USD Million)